NHS ester-PEG4-Val-Cit-PAB-MMAE

NHS ester-PEG4-Val-Cit-PAB-MMAE

NHS ester-PEG4-Val-Cit-PAB-MMAE can be used antibody drug conjugation as a precursor. It contains a PEG4 spacer, a protease-sensitive Val-Cit dipeptide, a PAB linker and an MMAE payload. Reagent grade, for research purpose. Please contact us for GMP-grade inquiries.

Molecular structure of the compound BP-25503
    • Unit
    • Price
    • Qty
    • 10 MG
    • $870.00
    • 25 MG
    • $1500.00
    • 50 MG
    • $2600.00

Usually ships within 24 hours.

Would you like to inquire about custom quantity?
Inquire

Product Citations

  1. Huang, C. H., Chang, E., Zheng, L., Raj, J. G. J., Wu, W., Pisani, L. J., & Daldrup-Link, H. E. (2023). Tumor protease-activated theranostic nanoparticles for MRI-guided glioblastoma therapy. Theranostics, 13(6), 1745–1758. https://doi.org/10.7150/thno.79342
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091873/